Document is current
Any future updates will be listed below
-
Authors
Englander, Zachary K.
Wei, Hong-Jian
Pouliopoulos, Antonios N.
Bendau, Ethan
Upadhyayula, Pavan
Jan, Chia-Ing
Spinazzi, Eleanora F.
Yoh, Nina
Tazhibi, Masih
McQuillan, Nicholas M.
Wang, Tony J. C.
Bruce, Jeffrey N.
Canoll, Peter
Feldstein, Neil A.
Zacharoulis, Stergios
Konofagou, Elisa E.
Wu, Cheng-Chia
-
Funding
Funding for this research was provided by:
National Institutes of Health (R38CA231577-01)
National Institutes of Health (5R01EB009041)
National Institutes of Health (5R01EB009041)
National Institutes of Health (5R01EB009041)
Gary and Yael Fegel Family Foundation
Matheson Foundation
Herbert Irving Cancer Center Support Grant
- License Information
-
More Information
Article History
Received: 16 July 2020
Accepted: 24 February 2021
First Online: 22 March 2021
Competing interests
: Dr. Spinazzi has a direct family member who is employed by Bracco Group. Dr. Wang reports personal fees and non-financial support from AbbVie, personal fees from AstraZeneca, personal fees from Cancer Panels, personal fees from Doximity, personal fees and non-financial support from Elekta, personal fees and non-financial support from Merck, personal fees and non-financial support from Novocure, personal fees and non-financial support from RTOG Foundation, personal fees from Rutgers, personal fees from University of Iowa, personal fees from Wolters Kluwer, grants and non-financial support from Genentech, outside the submitted work. Dr. Konofagou reports equity and non-financial support from Vesselon. The remaining authors do not have any competing interests.
